Profile data is unavailable for this security.
About the company
Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies.
- Revenue in USD (TTM)0.00
- Net income in USD98.00k
- Incorporated1983
- Employees0.00
- LocationEnzon Pharmaceuticals Inc20 Commerce Drive, Suite 135CRANFORD 07016United StatesUSA
- Phone+1 (732) 980-4500
- Fax+1 (302) 655-5049
- Websitehttp://enzon.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Portage Biotech Inc | 0.00 | -144.90m | 5.36m | 7.00 | -- | 0.1675 | -- | -- | -7.96 | -7.96 | 0.00 | 1.62 | 0.00 | -- | -- | 0.00 | -111.60 | -19.70 | -113.27 | -26.48 | -- | -- | -- | -- | -- | -- | 0.0087 | -- | -- | -- | -520.10 | -- | -- | -- |
Emmaus Life Sciences Inc | 28.46m | -4.74m | 5.36m | 55.00 | -- | -- | -- | 0.1885 | -0.0931 | -0.0931 | 0.3905 | -0.6773 | 0.6349 | 0.8184 | 9.36 | 517,454.50 | -10.58 | -- | -- | -- | 93.69 | -- | -16.66 | -- | 0.1249 | 0.1426 | -- | -- | -10.77 | -- | 33.37 | -- | -- | -- |
ProtoKinetix, Inc. | 0.00 | -415.48k | 5.40m | 0.00 | -- | 12.38 | -- | -- | -0.0012 | -0.0012 | 0.00 | 0.0013 | 0.00 | -- | -- | -- | -88.08 | -696.88 | -96.94 | -785.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 78.22 | -- | 10.78 | -- |
Halberd Corp | 281.24k | 25.34k | 5.40m | 3.00 | 3.66 | -- | 213.04 | 19.22 | 0.0023 | 0.0023 | 0.0018 | -0.0002 | 0.1449 | 0.0303 | 2.52 | -- | 1.31 | -- | 4.58 | -- | 50.00 | -- | 9.01 | -- | 0.2661 | 1.35 | 1.02 | -- | 271.52 | -- | -60.11 | -- | -- | -- |
Psycheceutical Bioscience Inc | 1.16m | -149.52k | 5.45m | 4.00 | -- | 0.058 | -- | 4.71 | -0.1157 | -0.1157 | 0.8953 | 0.3399 | 0.6308 | 98.60 | 2.34 | 289,232.50 | -8.15 | -- | -29.82 | -- | 60.50 | -- | -12.92 | -- | 0.959 | -- | 0.0906 | -- | -- | -- | -1,100.34 | -- | -- | -- |
NLS Pharmaceutics AG | 0.00 | -15.47m | 5.46m | 2.00 | -- | -- | -- | -- | -0.534 | -0.534 | 0.00 | -0.1322 | 0.00 | -- | -- | 0.00 | -714.74 | -308.05 | -- | -- | -- | -- | -- | -- | -- | -175.42 | -- | -- | -- | -- | -38.08 | -- | -- | -- |
Fresh Tracks Therapeutics Inc | 8.01m | -5.69m | 5.50m | 4.00 | -- | 0.5535 | -- | 0.6865 | -1.38 | -1.38 | 1.49 | 1.66 | 0.7326 | -- | -- | 2,001,500.00 | -52.10 | -89.76 | -66.50 | -115.24 | -- | -- | -71.12 | -442.61 | -- | -1,272.00 | 0.00 | -- | 15.31 | 37.62 | 73.02 | -- | -- | -- |
Synaptogenix Inc | 0.00 | -13.78m | 5.52m | 5.00 | -- | 0.2015 | -- | -- | -43.56 | -43.56 | 0.00 | 26.55 | 0.00 | -- | -- | 0.00 | -17.32 | -40.33 | -18.83 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
Enzon Pharmaceuticals Inc | 0.00 | 98.00k | 5.57m | 0.00 | 56.82 | 1.59 | -- | -- | 0.0013 | 0.0013 | 0.00 | 0.6197 | 0.00 | -- | -- | -- | 2.88 | -0.8654 | 2.99 | -0.8851 | -- | -- | -- | -159.43 | -- | -- | 0.00 | -- | -100.00 | -- | 106.71 | -55.86 | -- | -- |
Burzynski Research Institute Inc | 0.00 | -1.19m | 5.62m | 2.00 | -- | -- | -- | -- | -0.009 | -0.009 | 0.00 | -0.0003 | 0.00 | -- | -- | -- | -84,895.00 | -10,098.54 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 6.18 | -- | -- | -- |
Seelos Therapeutics Inc | 2.20m | -37.88m | 5.64m | 15.00 | -- | -- | -- | 2.56 | -8.95 | -8.95 | 0.4402 | -3.42 | 0.1564 | -- | -- | 146,866.70 | -269.01 | -180.05 | -- | -386.76 | -- | -- | -1,719.56 | -9,612.88 | -- | -- | -- | -- | -- | -- | 48.48 | -- | -- | -- |
Protagenic Therapeutics Inc | 0.00 | -5.00m | 5.68m | -- | -- | 1.55 | -- | -- | -1.15 | -1.15 | 0.00 | 0.8271 | 0.00 | -- | -- | -- | -80.91 | -74.49 | -94.48 | -92.56 | -- | -- | -- | -- | -- | -9.56 | 0.00 | -- | -- | -- | -40.64 | -- | -- | -- |
Sonnet Biotherapeutics Holdings Inc | 129.19k | -14.46m | 5.71m | 12.00 | -- | 2.22 | -- | 44.20 | -12.91 | -12.91 | 0.0676 | 0.8381 | 0.0251 | -- | 0.1688 | 10,765.83 | -281.29 | -- | -- | -- | -- | -- | -11,192.09 | -- | -- | -- | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
Integrated BioPharma, Inc. | 50.52m | -385.00k | 5.74m | 141.00 | -- | 0.309 | -- | 0.1136 | -0.0128 | -0.0128 | 1.68 | 0.6168 | 1.95 | 4.21 | 12.26 | 358,269.50 | -1.49 | 15.51 | -1.89 | 27.94 | 6.62 | 12.09 | -0.7621 | 6.44 | 0.8428 | -22.53 | 0.0015 | -- | -9.91 | 3.00 | -101.35 | -- | -14.03 | -- |
Soligenix Inc | 839.36k | -6.14m | 5.76m | 13.00 | -- | 1.66 | -- | 6.86 | -0.9164 | -0.9164 | 0.1085 | 0.243 | 0.0697 | -- | 5.86 | 64,566.15 | -51.01 | -75.40 | -872.23 | -154.32 | 11.59 | 22.83 | -731.60 | -620.02 | -- | -1,677.11 | 0.5639 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
HST Global Inc | 0.00 | -146.22k | 5.77m | 1.00 | -- | -- | -- | -- | -0.0279 | -0.0279 | 0.00 | -0.1128 | 0.00 | -- | -- | -- | -17,002.33 | -5,836.01 | -- | -- | -- | -- | -- | -- | -- | -26.54 | -- | -- | -- | -- | -0.7858 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Enzon Pharmaceuticals Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Icahn Associates Holding LLCas of 18 Apr 2023 | 36.06m | 48.58% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.